Methods for Evaluating Models, Tests And Biomarkers (MEMTAB): Abstracts from the 7th International Conference, MEMTAB 2025

2026, 10(1):S1It is now universally acknowledged: medical tests should be carefully evaluated before their use can be recommended in health care.Yet while trials became the cornerstone in the evaluation of pharmaceuticals and other interventions, the methods for evaluating laboratory tests, imaging, prediction models, and other forms of medical testing were trailing in the shadows of drug development.Why the delay?A combination of factors can be held responsible.Regulations that embraced drug oversight were introduced decades earlier, compared to tests.Tests do not directly save lives: there is an indirect link between testing and health outcomes.This presentation will timetravel through the evolution of test evaluation, then zoom forward with a cautious forecast of what is next. S2Value of information analysis: towards a value-based approach in biomarker and prediction model research